This prospective study had two objectives: firstly, to characterize the molecular basis and clinical spectrum in a cohort of dogs with hereditary methemoglobinemia; and secondly, to determine if there are biochemical or clinical phenotypic differences ascribed to separate CYB5R3 gene variants. The gene discussed is CYB5R3; the disease is methemoglobinemia.